Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-12-059410
Filing Date
2012-11-19
Accepted
2012-11-19 16:37:40
Documents
1
Period of Report
2012-11-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd360740.html 4  
1 FORM 4 rrd360740.xml 4 5537
  Complete submission text file 0001181431-12-059410.txt   6948
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Issuer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SANGAMO BIOSCIENCES IN STE.A-100 POINT RICHMOND TECH CENTER 501 CANA BLVD RICHMOND CA 94804
Business Address
MARTIN J TYLER (Reporting) CIK: 0001234388 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34207 | Film No.: 121215018